Topical antimicrobial activity of 6-methoxy-1-phenazinol 5,10-dioxide, cupric complex.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy; D003300:Copper / Q000494:pharmacology*; D003470:Culture Media; D004926:Escherichia coli / Q000187:drug effects; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D008864:Microsporum / Q000187:drug effects; D010087:Oxides / Q000494:pharmacology; D010619:Phenazines / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013292:Streptococcus agalactiae / Q000187:drug effects; D014005:Tinea / Q000188:drug therapy; D014249:Trichophyton / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D003470:Culture Media; D010087:Oxides; D010619:Phenazines; D003300:Copper